The effect of the combination of Malva sylvestris L. and Althaea digitata Boiss. on prevention of acute radiation proctitis in patients with prostate cancer

被引:2
作者
Moeini, Reihaneh [1 ,2 ]
Farhan, Farshid [3 ]
Mofid, Bahram [4 ]
Rezaeizadeh, Hossein [2 ]
Gorji, Narjes [1 ]
Ghobadi, Ali [5 ]
Jaladat, Amir Mohammad [6 ]
Khanavi, Mahnaz [7 ,8 ,9 ]
机构
[1] Babol Univ Med Sci, Sch Tradit Med, Dept Tradit Persian Med, Babol Sar, Iran
[2] Univ Tehran Med Sci, Fac Tradit Med, Dept Tradit Med, Tehran, Iran
[3] Univ Tehran Med Sci, Imam Khomeini Hosp, Fac Med, Dept Radiat Oncol,Canc Inst, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Fac Med, Dept Radiat Oncol, Shohada E Tajrish Hosp, Tehran, Iran
[5] Iran Univ Med Sci, Sch Tradit Med, Dept Tradit Pharm, Tehran, Iran
[6] Shiraz Univ Med Sci, Sch Med, Dept Tradit Persian Med, Shiraz, Iran
[7] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacognosy, Tehran, Iran
[8] Univ Tehran Med Sci, Persian Med & Pharm Res Ctr, Tehran, Iran
[9] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada
关键词
Malva sylvestris; Alcea digitata; Acute radiation therapy; Persian medicine; QUALITY-OF-LIFE; ANTIOXIDANT; EFFICACY; THERAPY;
D O I
10.1016/j.hermed.2018.01.005
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The effect of a combination of Malva sylvestris and Althaea digitata flower powder in prevention of acute radiation proctitis was assessed in patients undergoing radiation therapy (RT) for prostate cancer. This double-blind randomized controlled study was conducted at three centers in Iran. Before starting RT, patients (N = 65) received a 4 g packet of flower powder or placebo to use 3 times a day as an infusion from the first day of RT and for five consecutive weeks including the three weeks of RT. They were visited by a physician 3 times during this period. Acute morbidity was classified according to the Radiation Therapy Oncology Group (RTOG) criteria. Severity of proctitis symptoms was assessed by Visual Analog Scale (VAS) with 10 points. Non-statistical significant differences were observed between the groups in relation to RTOG grade criteria (grade 0: drug 22.8% (N = 8), placebo 10% (N = 3), difference 12.8%; grade 1: drug 65.8%, placebo 64.4%, difference 1.4%; grade 2: drug 11.4% (N = 8), placebo 26.6% (N = 4), difference 15.2%. (P = .059)) According to VAS, the most common complaint was anal burning and diarrhea in the flower powder group showing a significant decrease in these symptoms at the end of the study as compared to the placebo; flower powder (1.56 +/- 1.07) vs placebo (3.82 +/- 1.67) for burning (P < .05) and flower powder (1.06 +/- 0.58) vs placebo (1.95 +/- 0.79) for diarrhea (P = .046). The flower powder prevented anal discomfort and diarrhea induced by prostate radiotherapy, although there were no significant differences between the two groups in RTOG. No serious side effects were reported, so the combination could be suggested for patients who cannot tolerate symptoms of proctitis after further studies.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 48 条
[1]  
Ahmadlou N., 2009, JBUM, V11, P20
[2]   Can Angiotensin-Converting Enzyme Inhibitors Reduce the Incidence, Severity, and Duration of Radiation Proctitis? [J].
Alashkham, Abduelmenem ;
Paterson, Catherine ;
Rauchhaus, Petra ;
Nabi, Ghulam .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01) :93-101
[3]   Evaluation of Efficacy of an Herbal Compound on Dry Mouth in Patients With Head and Neck Cancers: A Randomized Clinical Trial [J].
Ameri, Ahmad ;
Heydarirad, Ghazaleh ;
Rezaeizadeh, Hossein ;
Choopani, Rasool ;
Ghobadi, Ali ;
Gachkar, Latif .
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2016, 21 (01) :30-33
[4]  
[Anonymous], 2013, INT J PHARM TECH RES
[5]  
Arzani M, 2009, TIBB AL AKBAR
[6]  
Avicenna, 1998, CANON OF MED
[7]   Anti-Inflammatory, Anti-Osteoclastogenic and Antioxidant Effects of Malva sylvestris Extract and Fractions: In Vitro and In Vivo Studies [J].
Benso, Bruna ;
Franchin, Marcelo ;
Massarioli, Adna Prado ;
Rizzato Paschoal, Jonas Augusto ;
Alencar, Severino Matias ;
Nobre Franco, Gilson Cesar ;
Rosalen, Pedro Luiz .
PLOS ONE, 2016, 11 (09)
[8]   Amifostine-induced fever: Case report and review of the literature [J].
Boehme, S ;
Wilson, DB .
PHARMACOTHERAPY, 2004, 24 (01) :155-158
[9]  
Boldyreva G., 2001, Patent, Patent No. [RU 2174007, 2174007]
[10]  
Boldyreva G., 2001, Patent, Patent No. [RU 2000-132313, 2000132313]